← Eichor
Study identifier: NCT03932773 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

Condition: Post Traumatic Stress Disorder  ·  Sponsor: The University of Texas at Dallas

PhaseNA
Planned participants330
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.

This description comes directly from the study's public registry record.

Talk to the study team

Elizabeth "Ellen" Morris, PhD  ·  214-883-3171  ·  neurolab@utdallas.edu

Jill Ritter, BS  ·  972-883-3171  ·  neurolab@utdallas.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Florida State University College of MedicineTallahassee, Florida, United StatesRecruiting
Metrocare Services of DallasAddison, Texas, United StatesRecruiting
The University of Texas at DallasDallas, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03932773